Parkinson's Disease Mechanisms and TreatmentsHeat shock proteins researchEnzyme Structure and FunctionPlant biochemistry and biosynthesisAntibiotic Resistance in Bacteria
Publications
33
Citations
483
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2013
Publication cadence
Publications per year over the last 10 years — averaging 1.2/year recently
Recent publications
- R1398 is the GTP-𝛾-phosphate sensor that drives the ROC G-domain switching mechanism unique to Parkinson's disease-associated LRRK2
Research Square · 2026
- Structural and biochemical basis of ROC-dependent activation of LRRK2
Research Square · 2026
- Structural and biochemical basis of ROC-dependent activation of LRRK2
PNAS Nexus · 2026
- Potency of human hematopoietic cells from a novel CD34+ isolation technique
Stem Cells Translational Medicine · 2025
- Allosteric differences dictate GroEL complementation of <i>E. coli</i>
The FASEB Journal · 2022
- Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
Trends in Biochemical Sciences · 2022
- Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL
mBio · 2021
- A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease
Parkinsonism & Related Disorders · 2021
- The Post-war Whereabouts of Colonial Policy Studies in Modern Japan : Trans-war History of Asian Studies in Japan
Journal of Japanology · 2021
- Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugs
Bioorganic & Medicinal Chemistry · 2020
- A revised 1.6 Å structure of the GTPase domain of the Parkinson’s disease-associated protein LRRK2 provides insights into mechanisms
Publisher · 2019
- Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections
PMC · 2019
- A revised 1.6 Å structure of the GTPase domain of the Parkinson’s disease-associated protein LRRK2 provides insights into mechanisms
bioRxiv (Cold Spring Harbor Laboratory) · 2019
- HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules
PMC · 2019
- Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections
Bioorganic & Medicinal Chemistry Letters · 2019
Publishes in
- PMC×4
- Journal of Medicinal Chemistry×2
- Bioorganic & Medicinal Chemistry Letters×2
- The FASEB Journal×2
- Author eBooks×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile